
Piasclédine 300mg box of 90 capsules
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Free delivery for orders over 89€*.
* in metropolitan France and excluding drugs
Indicated in the symptomatic treatment of osteoarthritis.
GO-ON ONE has been shown to have a beneficial effect in improving joint function and relieving pain caused by osteoarthritis. Several joints can be treated at the same time.
Dosage: Depending on the size of the joint, up to 6ml can be administered intra-articularly.
Composition: Viscoelastic solution of a defined molecular weight of purified hyaluronic acid, produced by fermentation.
Each syringe contains: Hyaluronic acid sodium salt 60mg
Excipients 6ml
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Indicated for the symptomatic treatment of osteoarthritis, particularly of the hip and knee. Chondrosulf contains chondroitin sulfate and is indicated for adults (over 15).
Chondrosulf is available in several dosages:
Chondrolsulf 400 mg box 84 capsules
Chondrolsulf 800 mg box 30 capsules
Sinogel® is indicated in cases of pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic conditions or damage to joints and tendons. Sinogel® is a synovial fluid substitute used to restore the physiological and rheological properties of osteoarthritic joints. Read instructions carefully before use. This medical device is a regulated healthcare product, and bears the CE mark (CE0477).
Indication: Indicated for the symptomatic treatment of osteoarthritis, particularly of the hip and knee. Chondrosulf contains chondroitin sulfate and is indicated for adults (over 15 years of age).
Chondrosulf is available in several dosages:
Chondrolsulf 400 mg box 84 capsules
Chondrolsulf 800 mg box 30 capsules
Delayed-effect symptomatic treatment of osteoarthritis of the hip and knee.
1200 mg oral gel: Sachets, box of 30.
Chondrosulf is available in several dosages:
Chondrolsulf 400 mg box 84 capsules
Chondrolsulf 800 mg box 30 capsules
Flector effigel is a medicine containing an anti-inflammatory and an analgesic, it is used in the short term local treatment, in adults and children over 15 years old, in case of benign trauma: sprain, strain, or contusion.
Indications: This product is indicated in adults (over 15 years of age) for the symptomatic treatment of pain of tendino-ligamentary origin, and post-traumatic pain: sprains and contusions. This drug is indicated in adults for the treatment of painful flare-ups of osteoarthritis of the knee, following initial medical advice.
Symptomatic treatment ofosteoarthritis.
Arthrum H viscoelastic devices are recommended to maintain the endo-articular space, reduce pain and restore joint mobility by replacing and supplementing the elastoviscosity of the pathological synovial fluid in osteoarthritic joints.
Description: HYALEXO EXPANSCIENCE is a hyaluronic acid-based medical device indicated for the relief of pain in patients suffering fromosteoarthritis or degenerative joint diseases resulting in an alteration of the functional properties of synovial fluid.
Description : GCA2700 Gel combines 16 targeted active ingredients, including Harpagophytum extract, Helichrysum floral water and Gaultheria essential oil with a soothing and relaxing fragrance.
Indications: Synvisc-One (a viscosupplement) is a simple intra-articular injection used to relieve pain and discomfort associated with osteoarthritis of the knee for up to six months.
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
This medicine is used as a ground modifier especially during infectious and viral conditions, flu-like conditions, inflammatory rheumatic conditions and during arthrosis.
Sinovial® HL is indicated for pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or tendinopathy linked to joint alterations.
Intra-articular injection of hyaluronic acid forarthropathy causing pain or limited mobility. This medical device is a regulated healthcare product, and carries the CE mark.
- Restore the viscoelastic properties of synovial fluid
- Reduce pain
- Improve joint mobility